Compare Lupin Ltd with Biocon Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

LUPIN vs BIOCON - Comparison Results

LUPIN     Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More


Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More


Current Valuations

P/E (TTM) x 47.5 19.4 244.3% View Chart
P/BV x 2.4 3.0 80.9% View Chart
Dividend Yield % 0.0 0.4 -  


5-Yr Chart
Click to enlarge
High Rs9861,188 83.0%   
Low Rs720305 236.2%   
Sales per share (Unadj.) Rs369.568.7 537.6%  
Earnings per share (Unadj.) Rs13.47.6 177.5%  
Cash flow per share (Unadj.) Rs37.414.0 267.6%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %00.1 0.0%  
Book value per share (Unadj.) Rs303.786.3 351.7%  
Shares outstanding (eoy) m452.49600.00 75.4%   
Bonus/Rights/Conversions ESOPIS-  
Price / Sales ratio x2.310.9 21.3%   
Avg P/E ratio x63.698.9 64.4%  
P/CF ratio (eoy) x22.853.4 42.7%  
Price / Book Value ratio x2.88.6 32.5%  
Dividend payout %013.2 0.0%   
Avg Mkt Cap Rs m386,064447,900 86.2%   
No. of employees `00017.76.1 287.6%   
Total wages/salary Rs m31,5139,311 338.4%   
Avg. sales/employee Rs Th9,453.86,705.8 141.0%   
Avg. wages/employee Rs Th1,782.01,514.2 117.7%   
Avg. net profit/employee Rs Th343.0736.9 46.5%   
Net Sales Rs m167,18241,234 405.4%  
Other income Rs m3,6402,062 176.5%   
Total revenues Rs m170,82243,296 394.5%   
Gross profit Rs m28,8228,291 347.6%  
Depreciation Rs m10,8503,851 281.7%   
Interest Rs m3,078615 500.5%   
Profit before tax Rs m18,5345,887 314.8%   
Minority Interest Rs m-89213 -41.9%   
Prior Period Items Rs m380-   
Extraordinary Inc (Exp) Rs m-3,4000-   
Tax Rs m9,0171,569 574.7%   
Profit after tax Rs m6,0664,531 133.9%  
Gross profit margin %17.220.1 85.7%  
Effective tax rate %48.726.7 182.5%   
Net profit margin %3.611.0 33.0%  
Current assets Rs m138,53641,486 333.9%   
Current liabilities Rs m61,29921,413 286.3%   
Net working cap to sales %46.248.7 94.9%  
Current ratio x2.31.9 116.7%  
Inventory Days Days8464 131.0%  
Debtors Days Days11294 119.4%  
Net fixed assets Rs m127,51650,661 251.7%   
Share capital Rs m9053,000 30.2%   
"Free" reserves Rs m136,51748,808 279.7%   
Net worth Rs m137,42251,808 265.3%   
Long term debt Rs m66,41717,898 371.1%   
Total assets Rs m279,49499,897 279.8%  
Interest coverage x7.010.6 66.4%   
Debt to equity ratio x0.50.3 139.9%  
Sales to assets ratio x0.60.4 144.9%   
Return on assets %3.35.2 63.5%  
Return on equity %4.48.7 50.5%  
Return on capital %8.99.6 92.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m59,41412,058 492.7%   
Fx outflow Rs m22,2827,348 303.2%   
Net fx Rs m37,1324,710 788.4%   
From Operations Rs m16,6606,621 251.6%  
From Investments Rs m-32,825-6,840 479.9%  
From Financial Activity Rs m7,441-2,397 -310.4%  
Net Cashflow Rs m-8,724-2,612 334.0%  

Share Holding

Indian Promoters % 46.6 40.4 115.3%  
Foreign collaborators % 0.2 20.6 1.0%  
Indian inst/Mut Fund % 11.3 8.4 134.5%  
FIIs % 31.9 10.7 298.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 19.9 50.8%  
Shareholders   98,259 109,995 89.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster


Compare LUPIN With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

BIOCON Announces Quarterly Results (1QFY20); Net Profit Down 11.5% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, BIOCON has posted a net profit of Rs 1 bn (down 11.5% YoY). Sales on the other hand came in at Rs 5 bn (down 57.2% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

BIOCON Announces Quarterly Results (4QFY19); Net Profit Down 53.8% (Quarterly Result Update)

Apr 26, 2019 | Updated on Apr 26, 2019

For the quarter ended March 2019, BIOCON has posted a net profit of Rs 705 m (down 53.8% YoY). Sales on the other hand came in at Rs 8 bn (down 34.7% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?


Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms


Oct 18, 2019 (Close)